State Board of Administration of Florida Retirement System
NGM

State Board of Administration of Florida Retirement System’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,654
Closed -$63.9K – 2425
2024
Q1 		$63.9K Buy
15,654
+4,330
+38% +$6.42K ﹤0.01% 2111
2023
Q4 		$9.73K Buy
+11,324
New +$9.94K ﹤0.01% 2420
2023
Q2 		– Sell
-15,654
Closed -$63.9K – 2533
2023
Q1 		$63.9K Hold
15,654
– – ﹤0.01% 2202
2022
Q4 		$78.6K Hold
15,654
– – ﹤0.01% 2240
2022
Q3 		$205K Hold
15,654
– – ﹤0.01% 2053
2022
Q2 		$201K Buy
+15,654
New +$217K ﹤0.01% 2116
2022
Q1 		– Sell
-12,316
Closed -$218K – 2410
2021
Q4 		$218K Sell
12,316
-4,658
-27% -$89.4K ﹤0.01% 2186
2021
Q3 		$357K Buy
+16,974
New +$374K ﹤0.01% 2020

State Board of Administration of Florida Retirement System's NGM Position: Q2 2024 in Review

State Board of Administration of Florida Retirement System sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 15,654 shares — an estimated $63.9K sold.

State Board of Administration of Florida Retirement System first reported a position in NGM in Q3 2021 and held it in 8 quarters. The position peaked at $357K in Q3 2021. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • State Board of Administration of Florida Retirement System reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 15,654 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $63.9K.
  • State Board of Administration of Florida Retirement System first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • State Board of Administration of Florida Retirement System's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $357K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2024, filed 8 Aug 2024.